Nature 1975,254(5495):34–38 PubMedCrossRef 13 Butcher SJ, Grimes

Nature 1975,254(5495):34–38.PubMedCrossRef 13. Butcher SJ, Grimes JM, Makeyev EV, Bamford DH, Stuart DI: A mechanism for initiating RNA-dependent RNA polymerization. Nature 2001, 410:235–240.PubMedCrossRef 14. Van Dijk AA, Frilander M, Bamford DH: Differentiation OSI-027 price between minus- and plus-strand synthesis: polymerase activity of dsRNA bacteriophage Φ6 in an in

vitro packaging and replication system. Virology 1995, 211:320–323.PubMedCrossRef 15. Mindich L: Bacteriophage Φ6: A unique virus having a lipid-containing membrane and a genome composed of three dsRNA segments. In Advances in Virus Research. Volume 35. Edited by: Maramorosch K, Murphy FA, Shatkin AJ. New York: Academic Press; 1988:137–176. 16. Qiao J, Qiao X, Sun Y, Mindich L: Isolation and analysis of mutants with altered packaging specificity in the dsRNA bacteriophage Φ6. J Bacteriol 2003, 185:4572–4577.PubMedCrossRef 17. Van Etten JL, Lane L, Gonzalez C, Partridge J, Vidaver A: Comparative properties of bacteriophage Φ6 and Φ6 nucleocapsid. J Virol 1976, 18:652–658. 18. Gottlieb P, Strassman J, Qiao X, Frucht A, Mindich L: In vitro replication, packaging and transcription of the segmented dsRNA genome of bacteriophage Φ6: studies with procapsids assembled from plasmid Protein Tyrosine Kinase inhibitor encoded proteins. J Bacteriol 1990, 172:5774–5782.PubMed 19. Emori Y, Iba H, Okada Y: Transcriptional regulation of three double-stranded RNA segments of bacteriophage Φ6 in vitro.

J Virology 1983, 46:196–203.PubMed Authors’ contributions JQ, XQ, YS and FD devised, carried out and NADPH-cytochrome-c2 reductase analyzed the experiments described in this report. LM conceived the project and drafted the manuscript. All authors read and approved the final manuscript.”
“Background Mycobacterium Caspase Inhibitor VI tuberculosis is a major global pathogen. In 2007, approximately 1.7 million

deaths were caused by tuberculosis (TB) and an estimated 9.3 million people acquired the infection [1]. Patients can usually be cured through a six month course of a multiple drug regimen [2]. The efficacy of chemotherapy has however been compromised by the appearance of multi- and extensively drug resistant strains [3, 4]. The search for potential novel drug targets and the subsequent development of new antibiotics is therefore urgent. Ideal candidates would be mycobacterial-specific and include pathways involved in the biosynthesis of the unusual cell envelope [5, 6]; the target of some existing antibiotics, including isoniazid, ethionamide, ethambutol and pyrazinamide [7]. Inositol is a polyol that is not synthesized in most bacterial species. However, in the mycobacteria, inositol is found in lipoarabinomannan (LAM), a lipoglycan that is present in high levels in the cell envelope. LAM is composed of a mannan backbone with branched arabinosyl chains. It is anchored in the cell envelope by means of a phosphatidylinositol (PI) moiety. Other lipoglycans found in the cell envelope include lipomannan (LM) and PI mannosides (PIMs).

Comments are closed.